Physician profile
Kari Joyner
NPI 1225454432
$7,418.98
in general payments reported to CMS, 2019-2025
41 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,526 · 2022: $1,374 · 2023: $1,512 · 2024: $1,579 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,430 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,429.52 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,571.08 | 2021-2025 | |
| Novo Nordisk INC | $849.37 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $523.20 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Pfizer INC. | $492.43 | 2021-2025 | |
| Amgen INC. | $470.49 | 2021-2025 | Otezla, Repatha, Otezla |
| Abbott Laboratories | $307.13 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $300.23 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $293.19 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $216.31 | 2021-2024 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.99 | 2021-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $178.91 | 2024-2025 | Veozah |
| Insulet Corporation | $159.20 | 2021-2025 | Omnipod |
| Teva Pharmaceuticals USA, INC. | $147.99 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $146.10 | 2021-2023 | |
| Exact Sciences Corporation | $142.22 | 2023-2025 | Cologuard Collection Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.